Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

BACKGROUND: Two large clinical trials have shown a reduced rate of breast cancer development in high-risk women in the initial 5 years of follow-up after use of aromatase inhibitors (MAP.3 and International Breast Cancer Intervention Study II [IBIS-II]). Here, we report blinded long-term follow-up r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lancet
Asıl Yazarlar: Cuzick, Jack, Sestak, Ivana, Forbes, John F, Dowsett, Mitch, Cawthorn, Simon, Mansel, Robert E, Loibl, Sibylle, Bonanni, Bernardo, Evans, D Gareth, Howell, Anthony
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961114/
https://ncbi.nlm.nih.gov/pubmed/31839281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(19)32955-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller